Twelve months of emicizumab prophylaxis in a severe hemophilia A man with inhibitor who failed immune tolerance induction: effectiveness, economic, and safety outcomes

被引：0
|
作者：
Camelo, Ricardo Mesquita [1 ]
de Medeiros, Tenille Capuxu [2 ]
de Albuquerque, Daniela Goncalves Braz [2 ]
Alvares-Teodoro, Juliana [3 ]
机构：
[1] Univ Fed Minas Gerais, Fac Med, 1020-101 Padre Eustaquio, Belo Horizonte, MG, Brazil
[2] Ctr Hematol & Hemoterapia Rio Grande Norte HEMONOR, Natal, RN, Brazil
[3] Univ Fed Minas Gerais, Fac Farm, Belo Horizonte, MG, Brazil
来源：
HEMATOLOGY TRANSFUSION AND CELL THERAPY | 2023年 / 45卷 / 01期
关键词：
D O I：
10.1016/j.htct.2021.02.010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：98 / 101
页数：4
相关论文
共 41 条
  • [1] Inhibitor status of patients with Hemophilia A who transition to Emicizumab after Immune Tolerance Induction
    Batsuli, Glaivy
    Greene, Amanda
    Meeks, Shannon L.
    Sidonio, Robert F., Jr.
    HAEMOPHILIA, 2020, 26 : 28 - 28
  • [2] ECONOMIC EVALUATION OF IMMUNE TOLERANCE INDUCTION FOR CHILDREN WITH SEVERE HEMOPHILIA A AND HIGH-RESPONDING INHIBITORS: A COST-EFFECTIVENESS ANALYSIS OF PROPHYLAXIS WITH EMICIZUMAB
    Camelo, R.
    Barbosa, M. M.
    Araujo, M. S.
    Muniz Junior, R. L.
    Guerra Junior, A. A.
    Godman, B.
    Rezende, S. M.
    Acurcio, F. D. A.
    Martin, A. P.
    Alvares-Teodoro, J.
    HAEMOPHILIA, 2023, 29 : 52 - 52
  • [3] Economic Evaluation of Immune Tolerance Induction in Children With Severe Hemophilia A and High-Responding Inhibitors: A Cost-Effectiveness Analysis of Prophylaxis With Emicizumab
    Camelo, Ricardo Mesquita
    Barbosa, Mariana Michel
    Araujo, Maiara Silva
    Muniz, Roberto Lucio, Jr.
    Guerra, Augusto Afonso, Jr.
    Godman, Brian
    Rezende, Suely Meireles
    Acurcio, Francisco de Assis
    Martin, Antony P.
    Alvares-Teodoro, Juliana
    VALUE IN HEALTH REGIONAL ISSUES, 2023, 34 : 31 - 39
  • [4] Immune tolerance induction in children with severe hemophilia A and inhibitor in Poland
    Klukowska, A.
    Laguna, P.
    Dobaczewski, G.
    Janik-Moszant, A.
    Kamienska, E.
    Koltan, A.
    Pietrys, D.
    Waleszkiewicz-Majewska, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1069 - 1070
  • [5] Predicted coagulation potential using an in vitro simulated model of emicizumab prophylaxis and immune tolerance induction therapy in hemophilia A patients with inhibitor
    Nakajima, Yuto
    Tonegawa, Hitoshi
    Noguchi-Sasaki, Mariko
    Nogami, Keiji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (06) : 789 - 796
  • [6] Predicted coagulation potential using an in vitro simulated model of emicizumab prophylaxis and immune tolerance induction therapy in hemophilia A patients with inhibitor
    Yuto Nakajima
    Hitoshi Tonegawa
    Mariko Noguchi-Sasaki
    Keiji Nogami
    International Journal of Hematology, 2021, 113 : 789 - 796
  • [7] Emicizumab wastage estimation for treating people with hemophilia A and inhibitors who failed immune tolerance induction according to the current Brazilian public health protocol
    Camelo, Ricardo
    Barbosa, Mariana Michel
    Clicia, Luila C.
    Guerra Junior, Augusto Afonso
    Acurcio, Francisco de Assis
    Alvares-Teodoro, Juliana
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 548 - 549
  • [8] EMICIZUMAB WASTE ESTIMATION FOR TREATING PEOPLE WITH HEMOPHILIA A AND INHIBITORS WHO FAILED IMMUNE TOLERANCE INDUCTION ACCORDING TO THE CURRENT BRAZILIAN PUBLIC HEALTH PROTOCOL
    Camelo, R. M.
    Barbosa, M. M.
    Henriques, L. C. M.
    Guerra Junior, A. A.
    Acurcio, F. D. A.
    Alvares-Teodoro, J.
    HAEMOPHILIA, 2023, 29 : 33 - 33
  • [9] Benefits of prophylactic emicizumab in enhancing immune tolerance induction in a boy with hemophilia A and very high inhibitor titer
    Sirachainan, Nongnuch
    Chuansumrit, Ampaiwan
    Parapakpenjune, Surapan
    Wongwerawattanakoon, Pakawan
    Lertthammakiat, Surapong
    Kadegasem, Praguywan
    Sasanakul, Werasak
    PEDIATRIC BLOOD & CANCER, 2021, 68 (09)
  • [10] RECURRENT INHIBITORS OCCURRED ON EMICIZUMAB PROPHYLAXIS IN A CHILD WITH HEMOPHILIA A WITH INHIBITORS AFTER IMMUNE TOLERANCE INDUCTION: A CASE REPORT
    Li, Z.
    Liu, G.
    Wu, R.
    HAEMOPHILIA, 2023, 29 : 93 - 94
12345